Normal and aberrant expression of cytokines in neoplastic cells from chronic lymphocytic leukemias
- 30 April 1993
- journal article
- Published by Elsevier in Human Immunology
- Vol. 36 (4), 249-258
- https://doi.org/10.1016/0198-8859(93)90132-k
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemiaBlood, 1989
- TUMOUR NECROSIS FACTOR IN B CHRONIC LYMPHOCYTIC LEUKAEMIABritish Journal of Haematology, 1989
- The malignant B cells from B-chronic lymphocytic leukemia patients release TAC-soluble interleukin-2 receptorsBlood, 1988
- TUMOUR NECROSIS FACTOR AS AN AUTOCRINE TUMOUR GROWTH FACTOR FOR CHRONIC B-CELL MALIGNANCIESThe Lancet, 1988
- Spontaneous production of interleukin 1 activity by chronic lymphocytic leukemic cellsBlood, 1987
- High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemiaBlood, 1987
- Heterogenity of B-cell growth factor receptor reactivity in healthy donors and in patients with chronic lymphatic leukemia: Relationship to B-cell-derived lymphokinesCellular Immunology, 1986
- A case of human B cell leukemia that implicates an autocrine mechanism in the abnormal growth of Leu 1 B cells.Journal of Clinical Investigation, 1986
- Impaired expression of cell surface receptors for B cell growth factor by chronic lymphocytic leukemia B cellsBlood, 1986
- Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2European Journal of Immunology, 1986